The Pacemaker Gets Physiological: OptimPacing and the Conduction System Race
Dr. Dereck Mush, MD, MBA
Abbott
Medical devices supporting cardiac pacing and defibrillation.
Abbott is known for medical devices supporting cardiac pacing and defibrillation. It sits in our Cardiovascular category.
What they do
Abbott announced FDA approval and CE Mark for the UltiSynq defibrillation lead on November 10, 2026. The lead is designed for implantation in the left bundle branch area to deliver cardiac pacing and defibrillation therapy, working with the heart's natural electrical system. Abbott cites the ASCEND CSP IDE trial in support of the announcement.
The record
- Vertical
- Cardiovascular
- Sub-segment
- Conduction system pacing
- Product type
- Device
- Stage
- Headquarters
- Not disclosed
- Region
- Founded
- Not disclosed
- Total funding
- Undisclosed
Also in Cardiovascular
More in Cardiovascular: Cardiovascular startups/HealthTech startup database
Related on The Signal
Dr. Dereck Mush, MD, MBA
From Remote Telemetry to Active Co-Management: Direct-to-Patient Hemodynamics in Heart Failure
Dr. Dereck Mush, MD, MBA
The Playbook Becomes the Product: Abridge, Local Pathways and the Fight for the Clinician's First Question
Dr. Dereck Mush, MD, MBA
Voice Is a Vital Sign Now? What DETECT-HF Proves and What It Does Not
Dr. Dereck Mush, MD, MBA